Detalles de la búsqueda
1.
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
N Engl J Med
; 383(23): 2207-2218, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33264544
2.
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 23(5): 659-670, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427471
3.
Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study.
Pancreatology
; 19(1): 64-72, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30396819
4.
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Eur Radiol
; 29(4): 1968-1977, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30324390
5.
Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Eur Radiol
; 29(5): 2729, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30547198
6.
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.
Br J Cancer
; 119(12): 1464-1470, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30467411
7.
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
Oncologist
; 23(11): 1271-e128, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120161
8.
Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.
Radiology
; 288(1): 218-225, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29924716
9.
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
Eur Radiol
; 27(3): 1096-1104, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27329522
10.
Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients.
Toxicol Appl Pharmacol
; 311: 113-116, 2016 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27720938
11.
Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.
Anticancer Drugs
; 27(2): 133-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26574999
12.
Environmental risk management: A participatory diagnosis from a rural school in Colombia.
Jamba
; 15(1): 1510, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059163
13.
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.
Oncologist
; 17(3): 339-45, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22363067
14.
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
Oncologist
; 17(7): 947-55, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22643538
15.
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study.
Oncologist
; 17(1): 15-25, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234633
16.
Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO).
Anticancer Drugs
; 23(6): 659-65, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22634799
17.
Super-resolution microscopy for the study of store-operated calcium entry.
Cell Calcium
; 104: 102595, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35561647
18.
Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers.
BMC Med Genomics
; 15(1): 45, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35246124
19.
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Eur J Surg Oncol
; 48(5): 1123-1132, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34872775
20.
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Eur J Cancer
; 177: 154-163, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335783